| NCT03821025 |
Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction |
https://ClinicalTrials.gov/show/NCT03821025 |
Recruiting |
University of Cape Town |
2020-12-31 |
| NCT03111732 |
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) |
https://ClinicalTrials.gov/show/NCT03111732 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT03086993 |
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03086993 |
Recruiting |
Delcath Systems Inc. |
2023-01-31 |
| NCT03058289 |
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 |
https://ClinicalTrials.gov/show/NCT03058289 |
Recruiting |
Intensity Therapeutics, Inc. |
2022-07-31 |
| NCT03044587 |
Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer |
https://ClinicalTrials.gov/show/NCT03044587 |
Recruiting |
AIO-Studien-gGmbH |
2019-12-31 |
| NCT03003065 |
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers |
https://ClinicalTrials.gov/show/NCT03003065 |
Recruiting |
Chinese University of Hong Kong |
2022-08-31 |
| NCT02958059 |
Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient |
https://ClinicalTrials.gov/show/NCT02958059 |
Recruiting |
Yonsei University |
2020-08-31 |
| NCT02853474 |
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy |
https://ClinicalTrials.gov/show/NCT02853474 |
Recruiting |
Centre Oscar Lambret |
2021-10-31 |
| NCT02841800 |
Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis |
https://ClinicalTrials.gov/show/NCT02841800 |
Completed |
National Taiwan University Hospital |
2018-08-30 |
| NCT02821754 |
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) |
https://ClinicalTrials.gov/show/NCT02821754 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT02591030 |
Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours |
https://ClinicalTrials.gov/show/NCT02591030 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2023-09-30 |
| NCT02575014 |
Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy |
https://ClinicalTrials.gov/show/NCT02575014 |
Enrolling by invitation |
Florida Hospital Tampa Bay Division |
2018-12-31 |
| NCT04298021 |
DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04298021 |
Recruiting |
Seoul National University Hospital |
2021-03-31 |
| NCT04298008 |
AZD6738 Plus Durvalumab in Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04298008 |
Recruiting |
Seoul National University Hospital |
2021-03-31 |
| NCT02375880 |
Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder |
https://ClinicalTrials.gov/show/NCT02375880 |
Completed |
Leap Therapeutics, Inc. |
2018-07-31 |
| NCT02349412 |
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers |
https://ClinicalTrials.gov/show/NCT02349412 |
Completed |
Alliance for Clinical Trials in Oncology |
2017-07-03 |
| NCT02293954 |
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer |
https://ClinicalTrials.gov/show/NCT02293954 |
Active, not recruiting |
City of Hope Medical Center |
2020-06-30 |
| NCT02115542 |
Single Agent Regorafenib in Refractory Advanced Biliary Cancers |
https://ClinicalTrials.gov/show/NCT02115542 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2018-12-10 |
| NCT02088775 |
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer |
https://ClinicalTrials.gov/show/NCT02088775 |
Active, not recruiting |
Fox Chase Cancer Center |
2016-09-08 |
| NCT01313377 |
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01313377 |
Completed |
UNICANCER |
2016-06-30 |
| NCT02042443 |
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02042443 |
Completed |
National Cancer Institute (NCI) |
2017-01-31 |
| NCT01954745 |
Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01954745 |
Completed |
Massachusetts General Hospital |
2015-06-30 |
| NCT01845337 |
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine |
https://ClinicalTrials.gov/show/NCT01845337 |
Active, not recruiting |
University of Edinburgh |
2021-07-30 |
| NCT01766219 |
CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01766219 |
Completed |
Wake Forest University Health Sciences |
2018-04-30 |
| NCT01643499 |
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT01643499 |
Completed |
University of Chicago |
2016-08-28 |
| NCT01640522 |
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms |
https://ClinicalTrials.gov/show/NCT01640522 |
Completed |
University of Pittsburgh |
2013-12-31 |
| NCT01534637 |
Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT01534637 |
Completed |
Wake Forest University Health Sciences |
2009-12-31 |
| NCT01459965 |
Stenting Malignant Jaundice for Quality of Life |
https://ClinicalTrials.gov/show/NCT01459965 |
Completed |
Indiana University |
2004-11-30 |
| NCT01425879 |
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01425879 |
Completed |
National Cancer Institute (NCI) |
2013-05-31 |
| NCT04404647 |
Irreversible Electroporation of Unresectable Liver Tumors |
https://ClinicalTrials.gov/show/NCT04404647 |
Recruiting |
Aalborg University Hospital |
2025-03-30 |
| NCT04337333 |
Two-in-one Covered and Uncovered Metal Stent |
https://ClinicalTrials.gov/show/NCT04337333 |
Recruiting |
Ajou University School of Medicine |
2020-12-31 |
| NCT04276090 |
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04276090 |
Recruiting |
University of Kentucky |
2023-05-01 |
| NCT04152018 |
Study of PF‑06940434 in Patients With Advanced or Metastatic Solid Tumors. |
https://ClinicalTrials.gov/show/NCT04152018 |
Recruiting |
Pfizer |
2024-03-02 |
| NCT04076761 |
Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04076761 |
Recruiting |
Sunnybrook Health Sciences Centre |
2021-09-30 |
| NCT04072445 |
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04072445 |
Recruiting |
Mayo Clinic |
2021-05-15 |
| NCT03768414 |
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT03768414 |
Recruiting |
Southwest Oncology Group |
2024-01-01 |
| NCT03763214 |
PTFE Stents for Treatment of Malignant Biliary Strictures |
https://ClinicalTrials.gov/show/NCT03763214 |
Recruiting |
Johann Wolfgang Goethe University Hospital |
2020-03-31 |
| NCT03708445 |
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT03708445 |
Completed |
Gangnam Severance Hospital |
2020-01-22 |
| NCT03679338 |
Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT03679338 |
Recruiting |
Institut Paoli-Calmettes |
2020-11-30 |
| NCT03602079 |
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene |
https://ClinicalTrials.gov/show/NCT03602079 |
Recruiting |
Klus Pharma Inc. |
2020-10-31 |
| NCT03475966 |
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program |
https://ClinicalTrials.gov/show/NCT03475966 |
Recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2019-12-31 |
| NCT03447691 |
Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery |
https://ClinicalTrials.gov/show/NCT03447691 |
Recruiting |
Yonsei University |
2022-08-28 |
| NCT01256047 |
Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy |
https://ClinicalTrials.gov/show/NCT01256047 |
Completed |
Chiba University |
2014-03-31 |
| NCT01256034 |
Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy |
https://ClinicalTrials.gov/show/NCT01256034 |
Completed |
Chiba University |
2012-03-31 |
| NCT01232101 |
Covered or Uncovered Bile Duct Stents |
https://ClinicalTrials.gov/show/NCT01232101 |
Completed |
Göteborg University |
2009-06-30 |
| NCT01134276 |
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers |
https://ClinicalTrials.gov/show/NCT01134276 |
Completed |
Seoul National University Hospital |
2013-05-31 |
| NCT01093222 |
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01093222 |
Completed |
National Cancer Institute (NCI) |
2012-09-30 |
| NCT01041612 |
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi |
https://ClinicalTrials.gov/show/NCT01041612 |
Completed |
Taewoong Medical Co., Ltd. |
2012-09-30 |
| NCT00987766 |
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer |
https://ClinicalTrials.gov/show/NCT00987766 |
Completed |
Vanderbilt-Ingram Cancer Center |
2013-07-31 |
| NCT00930410 |
Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor |
https://ClinicalTrials.gov/show/NCT00930410 |
Completed |
Institut Paoli-Calmettes |
2012-05-31 |
| NCT00919061 |
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy |
https://ClinicalTrials.gov/show/NCT00919061 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-03-31 |
| NCT01683240 |
Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones |
https://ClinicalTrials.gov/show/NCT01683240 |
Completed |
Universitätsklinikum Hamburg-Eppendorf |
2016-02-29 |
| NCT02028845 |
Loop-tipped Guidewire in Selective Biliary Cannulation |
https://ClinicalTrials.gov/show/NCT02028845 |
Completed |
Ajou University School of Medicine |
2015-12-31 |
| NCT00789958 |
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct |
https://ClinicalTrials.gov/show/NCT00789958 |
Completed |
Southwest Oncology Group |
2014-12-31 |
| NCT00654160 |
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00654160 |
Completed |
Mayo Clinic |
2010-11-30 |
| NCT00639314 |
Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy |
https://ClinicalTrials.gov/show/NCT00639314 |
Completed |
Wakayama Medical University |
2009-05-31 |
| NCT00634751 |
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma |
https://ClinicalTrials.gov/show/NCT00634751 |
Completed |
University of Wisconsin, Madison |
2010-07-31 |
| NCT00628186 |
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy |
https://ClinicalTrials.gov/show/NCT00628186 |
Completed |
Wakayama Medical University |
2007-08-31 |
| NCT00553332 |
Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00553332 |
Completed |
National Cancer Institute (NCI) |
2013-01-31 |
| NCT00544193 |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00544193 |
Completed |
City of Hope Medical Center |
2012-08-31 |
| NCT00513539 |
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00513539 |
Completed |
University College, London |
2009-12-31 |
| NCT00486356 |
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00486356 |
Completed |
University of Nebraska |
2010-01-31 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00363584 |
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00363584 |
Completed |
National Cancer Institute (NCI) |
2013-08-31 |
| NCT00356889 |
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors |
https://ClinicalTrials.gov/show/NCT00356889 |
Completed |
National Cancer Institute (NCI) |
2008-10-31 |
| NCT00304135 |
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00304135 |
Completed |
Federation Francophone de Cancerologie Digestive |
2012-12-31 |
| NCT00280709 |
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction |
https://ClinicalTrials.gov/show/NCT00280709 |
Completed |
University Hospital, Linkoeping |
2008-10-31 |
| NCT00266097 |
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00266097 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2009-03-31 |
| NCT00262769 |
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors |
https://ClinicalTrials.gov/show/NCT00262769 |
Completed |
University College, London |
2008-08-31 |
| NCT00238212 |
S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00238212 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00183846 |
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT00183846 |
Completed |
University of Southern California |
2007-10-31 |
| NCT00107536 |
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00107536 |
Completed |
National Cancer Institute (NCI) |
2009-05-31 |
| NCT00101036 |
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00101036 |
Completed |
National Cancer Institute (NCI) |
2009-01-31 |
| NCT00003557 |
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00003557 |
Completed |
University of Chicago |
2000-06-30 |
| NCT00084942 |
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder |
https://ClinicalTrials.gov/show/NCT00084942 |
Completed |
Roswell Park Cancer Institute |
2004-05-31 |
| NCT00004604 |
Biological Therapy in Treating Patients With Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00004604 |
Completed |
Duke University |
2001-06-30 |
| NCT00003427 |
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00003427 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-04-30 |
| NCT00005938 |
DX-8951f in Treating Patients With Biliary Cancer |
https://ClinicalTrials.gov/show/NCT00005938 |
Completed |
Daiichi Sankyo, Inc. |
2005-04-30 |
| NCT00019474 |
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer |
https://ClinicalTrials.gov/show/NCT00019474 |
Completed |
Montefiore Medical Center |
2000-08-31 |
| NCT00003411 |
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT00003411 |
Completed |
University of Pittsburgh |
2002-06-30 |
| NCT00003923 |
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas |
https://ClinicalTrials.gov/show/NCT00003923 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-02-28 |
| NCT00009893 |
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00009893 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-01-31 |
| NCT00073905 |
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00073905 |
Completed |
Swiss Group for Clinical Cancer Research |
2006-06-30 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00033462 |
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00033462 |
Completed |
National Cancer Institute (NCI) |
2006-11-30 |
| NCT00004910 |
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction |
https://ClinicalTrials.gov/show/NCT00004910 |
Completed |
Northwestern University |
2003-02-28 |
| NCT00004895 |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00004895 |
Completed |
Northwestern University |
2002-10-31 |
| NCT00059865 |
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00059865 |
Completed |
Alliance for Clinical Trials in Oncology |
2007-02-28 |
| NCT00033540 |
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00033540 |
Completed |
Southwest Oncology Group |
2008-04-30 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00021047 |
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor |
https://ClinicalTrials.gov/show/NCT00021047 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00019513 |
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00019513 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |